Impact of a multilevel hospital intervention on hepatitis screening and risk management in neuroinflammatory patients receiving immune therapy
{{output}}
Background: Patients with neuroinflammatory disorders receiving immune therapy are at risk of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivation, particularly in endemic regions. However, adherence to recommended he... ...
